Thursday, December 7, 2023
Targeting costly meds, Biden admin asserts authority to seize certain drug patents - POLITICO
The determination, which was described by three people familiar with the matter, represents the culmination of a nearly nine-month review of the government's so-called march-in rights. Progressives have long insisted that those rights empower the administration to break the patents of pricey drugs that were developed with public funds, in an effort to create more competition and lower prices...
Subscribe to:
Post Comments (Atom)
Click Older Posts above to see more.
No comments:
Post a Comment